Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2011)Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas Ann Surg Oncol 18 3353-3361

[3] Siegel RL(2008)Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2451-2457

[4] Laversanne M(2020)Distribution of residual disease and recurrence patterns in pathological responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma Ann Surg 276 298-304

[5] Soerjomataram I(2019)Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma Anticancer Res 39 1433-1440

[6] Jemal A(2021)Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer N Engl J Med 384 1191-1203

[7] Miyata H(2021)Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy Ann Oncol 32 590-599

[8] Yamasaki M(2014)Factors associated with early recurrence and death after esophagectomy for cancer J Surg Oncol 109 459-464

[9] Kurokawa Y(2009)Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification Ann Surg 250 798-807

[10] Takiguchi S(2015)Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy Eur J Cardiothorac Surg 48 455-460

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2011)Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas Ann Surg Oncol 18 3353-3361

[3] Siegel RL(2008)Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection Ann Surg Oncol 15 2451-2457

[4] Laversanne M(2020)Distribution of residual disease and recurrence patterns in pathological responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma Ann Surg 276 298-304

[5] Soerjomataram I(2019)Early recurrence and cancer death after trimodal therapy for esophageal squamous cell carcinoma Anticancer Res 39 1433-1440

[6] Jemal A(2021)Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer N Engl J Med 384 1191-1203

[7] Miyata H(2021)Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy Ann Oncol 32 590-599

[8] Yamasaki M(2014)Factors associated with early recurrence and death after esophagectomy for cancer J Surg Oncol 109 459-464

[9] Kurokawa Y(2009)Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification Ann Surg 250 798-807

[10] Takiguchi S(2015)Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy Eur J Cardiothorac Surg 48 455-460